Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Amortizatization of Intangibles (2022 - 2025)

Axsome Therapeutics' Amortizatization of Intangibles history spans 4 years, with the latest figure at -$330000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 46.02% year-over-year to -$330000.0; the TTM value through Dec 2025 reached $1.3 million, down 50.64%, while the annual FY2025 figure was $1.3 million, 50.64% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was -$330000.0 at Axsome Therapeutics, down from $684000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.6 million in Q4 2022 and bottomed at -$330000.0 in Q4 2025.
  • The 4-year median for Amortizatization of Intangibles is $582000.0 (2023), against an average of $683165.6.
  • The largest YoY upside for Amortizatization of Intangibles was 1555.7% in 2024 against a maximum downside of 149.78% in 2024.
  • A 4-year view of Amortizatization of Intangibles shows it stood at $1.6 million in 2022, then plummeted by 71.75% to $454000.0 in 2023, then plummeted by 149.78% to -$226000.0 in 2024, then tumbled by 46.02% to -$330000.0 in 2025.
  • Per Business Quant, the three most recent readings for AXSM's Amortizatization of Intangibles are -$330000.0 (Q4 2025), $684000.0 (Q3 2025), and $537000.0 (Q2 2025).